Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P42345 (
mTOR
)
26,049
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Phosphoglycerate kinase 1
(
PGK1
) catalyzes the reversible transfer of a phosphoryl group from 1, 3-bisphosphoglycerate (1, 3-BPG) to ADP, producing 3-phosphoglycerate (3-PG) and ATP.
PGK1
plays a key role in coordinating glycolytic energy production with one-carbon metabolism, serine biosynthesis, and cellular redox regulation. Here, we report that
PGK1
is acetylated at lysine 220 (K220), which inhibits
PGK1
activity by disrupting the binding with its substrate, ADP. We have identified KAT9 and HDAC3 as the potential acetyltransferase and deacetylase, respectively, for
PGK1
. Insulin promotes K220 deacetylation to stimulate
PGK1
activity. We show that the PI3K/AKT/
mTOR
pathway regulates HDAC3 S424 phosphorylation, which promotes HDAC3-
PGK1
interaction and
PGK1
K220 deacetylation. Our study uncovers a previously unknown mechanism for the insulin and
mTOR
pathway in regulation of glycolytic ATP production and cellular redox potential via HDAC3-mediated
PGK1
deacetylation.
...
PMID:Insulin and mTOR Pathway Regulate HDAC3-Mediated Deacetylation and Activation of PGK1. 2653 68